Jeff Bezos Is Backing AI Drug Development Startup Profluent To that end, Profluent said Wednesday that it had raised $106 million in new venture funding led by Jeff Bezos’s Bezos Expeditions and Altimeter Capital, bringing total investment to $150 million
Profluent Raises $106M to Scale Frontier AI Models for . . . Altimeter Capital and Bezos Expeditions lead the round, bringing total funding to $150M to accelerate the design of genome editors, antibodies, and enzymes for real-world impact Profluent, a leader in frontier AI for protein design, today announced a $106 million financing co-led by Altimeter Capital and Bezos Expeditions, with participation from existing investors including Spark Capital
Profluent Raises $106M to Accelerate Frontier AI Models for . . . Profluent, an AI-driven biotech startup specializing in protein design, announced a $106 million financing round co-led by Altimeter Capital and Bezos Expeditions, with Jeff Bezos providing direct support 1 2 3 The new round brings Profluent’s total funding to $150 million since its founding in 2022 3 5
Why Jeff Bezos backed Profluent’s $106M bet on writing . . . Profluent builds frontier AI systems to program biology The company has raised $106M led by Bezos Expeditions and Altimeter, with continued support from Air Street, Spark, and Insight This new capital accelerates the company’s path toward scaling frontier protein models and, ultimately, delivering the first AI-designed therapeutic to a human patient
AI Biotech Startup Profluent Lands $106 million Co-led by . . . AI biotech startup Profluent has secured $106M to accelerate its frontier protein design models and expand its next-gen biologics pipeline, backed by Altimeter Capital and Bezos Expeditions in a major push toward programmable biology